Intrinsic Value of S&P & Nasdaq Contact Us

Bristol-Myers Squibb Company BMY NYSE

NYSE • Healthcare • Drug Manufacturers - General • US • USD

SharesGrow Score
56/100
2/7 Pass
SharesGrow Intrinsic Value
$39.61
-31.8%
Analyst Price Target
$62.73
+8%

Stock Statistics — BMY

Bristol-Myers Squibb Company (BMY) has a market capitalization of $118.58B and trades at $58.08. The 52-week range is 42.52-62.89.

Key metrics include a trailing Price-to-Earnings (P/E) ratio of 16.8, Earnings Per Share (EPS) of $3.46, annual revenue of $48.19B.

The stock has a beta of 0.27, a last dividend of $2.5000, operates in the Healthcare sector.

Trading Data
Current Price$58.08
52-Week Range42.52-62.89
Volume6.95M
Avg Volume (30D)13.15M
Market Cap$118.58B
Beta (1Y)0.27
Last Dividend$2.5000
Company
IPO Date1972-06-01
Employees34,100
CEOChristopher S. Boerner
CountryUS
ExchangeNYSE
CurrencyUSD
ISINUS1101221083
CUSIP110122108
Income (Latest Year)
Revenue$48.19B
Gross Profit$32.6B
EBITDA$14.55B
Operating Income$12.7B
Net Income$7.05B
EPS$3.46
EPS Diluted$3.45
Shares Outstanding$2.04B
Balance Sheet (Latest Year)
Total Assets$90.04B
Current Assets$29.39B
Cash & ST Investments$10.67B
Total Liabilities$71.53B
Total Debt$47.14B
Net Debt$36.93B
Total Equity$18.51B
Debt / Equity2.55
Valuation Ratios
P/E Ratio16.8
P/S Ratio2.46
P/B Ratio6.41
EV/EBITDA (approx)8.2
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message